BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30528360)

  • 1. Racial disparities in treatment and survival from ovarian cancer.
    Hildebrand JS; Wallace K; Graybill WS; Kelemen LE
    Cancer Epidemiol; 2019 Feb; 58():77-82. PubMed ID: 30528360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer.
    Chen F; Bailey CE; Alvarez RD; Shu XO; Zheng W
    Gynecol Oncol; 2021 Jan; 160(1):10-15. PubMed ID: 33208254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial Disparities in the Receipt of Guideline Care and Cancer Deaths for Women with Ovarian Cancer.
    Cronin KA; Howlader N; Stevens JL; Trimble EL; Harlan LC; Warren JL
    Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):539-545. PubMed ID: 30487136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
    Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
    Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
    Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
    J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in treatment and survival among elderly ovarian cancer patients.
    Taylor JS; He W; Harrison R; Zhao H; Sun CC; Lu KH; Giordano SH; Meyer LA
    Gynecol Oncol; 2018 Nov; 151(2):269-274. PubMed ID: 30253875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in care among patients with low-grade serous ovarian carcinoma.
    Siemon J; Galli J; Slomovitz B; Schlumbrecht M
    Gynecol Oncol; 2020 Apr; 157(1):46-54. PubMed ID: 32008792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago.
    Joslin CE; Brewer KC; Davis FG; Hoskins K; Peterson CE; Pauls HA
    Gynecol Oncol; 2014 Nov; 135(2):285-91. PubMed ID: 25173584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial disparities in the treatment of advanced epithelial ovarian cancer.
    Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
    Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do differences in medical comorbidities and treatment impact racial disparities in epithelial ovarian cancer?
    Dilley S; Erickson BK; Phillips CE; Kennemer CR; Zhang B; Matin T; Martin JY; Shah MM; Michael Straughn J; Leath CA
    Gynecol Oncol; 2018 Apr; 149(1):49-52. PubMed ID: 29605050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
    Felix AS; Cohn DE; Brasky TM; Zaino R; Park K; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Randall ME; Brinton LA
    Am J Obstet Gynecol; 2018 Nov; 219(5):459.e1-459.e11. PubMed ID: 30096321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparities in survival in malignant germ cell tumors of the ovary.
    Hinchcliff E; Rauh-Hain JA; Clemmer JT; Diver E; Hall T; Stall J; Growdon W; Clark R; Schorge J
    Gynecol Oncol; 2016 Mar; 140(3):463-9. PubMed ID: 26773470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois.
    Brewer KC; Peterson CE; Davis FG; Hoskins K; Pauls H; Joslin CE
    Ann Epidemiol; 2015 Aug; 25(8):556-63. PubMed ID: 25986734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
    Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
    Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
    Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
    J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States.
    Chan JK; Zhang M; Hu JM; Shin JY; Osann K; Kapp DS
    J Surg Oncol; 2008 Feb; 97(2):103-7. PubMed ID: 17979133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Have racial disparities in ovarian cancer increased over time? An analysis of SEER data.
    Terplan M; Schluterman N; McNamara EJ; Tracy JK; Temkin SM
    Gynecol Oncol; 2012 Apr; 125(1):19-24. PubMed ID: 22108636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
    Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
    Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial and Socioeconomic Treatment Disparities in Adolescents and Young Adults with Stage II-III Rectal Cancer.
    Lee DY; Teng A; Pedersen RC; Tavangari FR; Attaluri V; McLemore EC; Stern SL; Bilchik AJ; Goldfarb MR
    Ann Surg Oncol; 2017 Feb; 24(2):311-318. PubMed ID: 27766558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Black race may be associated with worse overall survival in renal cell carcinoma patients.
    Anastos H; Martini A; Waingankar N; Paulucci DJ; Beksac AT; Daza J; Patel HV; Gin GE; Sfakianos JP; Badani KK
    Urol Oncol; 2020 Dec; 38(12):938.e9-938.e17. PubMed ID: 32950398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.